THIRTY cases of blood clots after having the AstraZeneca vaccine have now been reported in UK - six times the number previously known.
But officials stressed it is still safe and there was no need to suspend jabs like in some European countries.
🦠 Read our coronavirus live blog for the latest news & updates...
The Medicines and Healthcare products Regulatory Agency (MHRA) revealed the figures last night.
It said 25 new cases are in addition to the five reported earlier this month.
Of those, 22 are the rare CVST kind of clot that caused concern in Europe and eight were other thrombosis events.
That is out of 18.1million doses administered in the UK - making it extremely rare at around one in 600,000.
No clots were reported in those given the Pfizer/BioNTech vaccine.
It comes as:
- Brits have been warned we could all face a fourth lockdown if huge groups meet over Easter
- Millions of Brits told book your Covid vaccine now without delay, by NHS chief
- Brits will likely have to take Covid tests or show immunity to go to the pub, says Boris
- EU chief warns Britain will get ‘ZERO’ AstraZeneca jabs until supplies are met saying ‘there’s nothing to negotiate'
- Easter Covid lockdown rules: What you can and can’t do over the UK bank holiday
Fears over the safety of the Oxford/AstraZeneca jab led 20 European countries to suspend vaccinations last month.
Most resumed after the European Medicines Agency (EMA) ruled the vaccine was safe for all ages.
But France and Germany have said it should not be given to younger patients who are thought to be more at risk of clots.
Millions of people across the world have had the cheap and effective AstraZeneca vaccine without any complications.
Regulators have stressed that the benefits of the jab far outweigh any potential risks.
The condition called CVST occurred in a small number of patients with low blood platelets and is an extremely rare combination of events.
It’s so rare, UK regulators at the MHRA said they did not know how often it happens in the general population.
While investigations continue, people have been urged to accept their vaccine offer when it comes.
Scientists say they know how jab could potentially cause blood clots
Scientists believe they have uncovered why people who have recently had the AstraZeneca Covid vaccine have suffered blood clots
A handful of the millions of people who have received the vaccine in Europe have experienced the extremely rare complication.
While it is still uncertain whether this was directly caused by the vaccine, scientists in Europe say they have an explanation.
Two studies, in Germany and Norway, claim the shot may cause the body to activate its own platelets - blood cells which form clots to stop bleeding.
This causes the blood to thicken, leading to potentially deadly clots.
Noweigan professor Pål Andre Holme claimed this was the “most likely” cause.
'WEAK EVIDENCE'
But independent scientists said the theory is based on the "weakest evidence", and gave no further answers.
Millions of people across the world have had the AstraZeneca vaccine - developed by Oxford University - without any complications.
Regulators have stressed that the benefits of the jab, to prevent Covid deaths, far outweigh any potential risks.
European regulators say there is no overall increased risk of blood clots in people who get the shot, or that from Pfizer.
But it is unclear whether a very small number of brain blood clots - including five in the UK, one of whom died - were the result of the jab.
The condition, called CVST, occurred with low blood platelets and is an extremely rare combination of events.
It’s so rare, UK regulators at the MHRA said they did not know how often it happens in the general population.
ACCEPT JAB
While investigations continue, people have been urged to accept their vaccine offer when it comes.
If anyone experiences headaches or severe bruising after their jab, they should seek medical help immediately, experts have warned.
The German study, led by the University of Greifswald, looked at nine patients in Germany and Austria who had some form of blood clotting after one AZ shot, seven of whom had a blood clot.
They believe the phenomenon is similar to a rare disorder that occurs with a blood thinning drug called heparin.
Heparin can trigger the immune system to create antibodies that fire up the platelets.
This is called “heparin-induced thrombocytopenia (HIT)”, and can also be caused by other drugs, leading the scientists to believe it could be the case for the AZ jab, too.
Researchers said four people studied had these antibodies in the blood.
And 20 individuals who received the vaccine but did not develop clots did not have these antibodies.
'INSECURE CONCLUSION'
Adam Finn, professor of paediatrics at the University of Bristol, said the study had “several limitations” that make its findings less convincing.
For example, it was not investigated whether the patients had previously had Covid - a risk factor for blood clotting in itself.
He said: “The authors’ conclusion that the relationship with vaccination is causative seems insecure at this point and further information on incidence and mechanism in this and other populations is therefore urgently needed to resolve this question."
Similar reports of rare blood clots have caused France, Sweden, Finland and Canada, as well as Germany, to recommend that younger people avoid the shot.
The jab is suspended altogether in Norway, where of the 120,000 recipients, six suffered clots and four died. It's also not in use in Denmark.
In Germany, 31 cases have been reported after 2.7m vaccinations, including 29 women aged between 20 and 63, and two men aged 36 and 57.
Nine of them have died.
Most read in News
Officials currently say there's not enough evidence to slow the jabs roll-out.
Dr June Raine, chief executive of the MHRA, said: "The benefits of Covid-19 vaccine AstraZeneca in preventing Covid-19 infection and its complications continue to outweigh any risks and the public should continue to get their vaccine when invited to do so."
READ MORE SUN STORIES
Johannes Oldenburg, a professor of medicine at Bonn university in Germany, told the : “If I had a choice between immediate vaccination with AstraZeneca or waiting four weeks for Moderna, then I would choose the AstraZeneca vaccine, because the four weeks of protection far outweighs this risk."
Oxford university and AstraZeneca say their trials show the vaccine is safe and effective and that they are continuing to monitor for side effects.